Financial Performance - The company's revenue for the nine months ended September 30, 2024, was 492.2 million MYR, a decrease of 5.9% compared to 522.8 million MYR in the same period last year[4]. - The profit for the period was approximately 88.8 million MYR, representing an 18.1% decrease from 108.4 million MYR in the previous year[5]. - The gross profit for the nine months was 141.2 million MYR, compared to 155.7 million MYR in the previous year, indicating a decline[4]. - Basic and diluted earnings per share for the nine months were 3.73 sen, down from 4.54 sen in the same period last year[4]. - The company reported total comprehensive income of 88.5 million MYR for the nine months, down from 108.4 million MYR in the previous year[9]. - The operating profit before tax for the nine months ended September 30, 2024, was 89.9 million MYR, down from 110.9 million MYR in the previous year[28]. - Cash generated from operating activities for the nine months ended September 30, 2024, was 141.7 million MYR, compared to 217.2 million MYR for the same period in 2023[24]. - EBITDA decreased by 15.1% to RM 104.1 million from RM 122.6 million in the previous year[50]. - The overall decrease in net profit and EBITDA was attributed to reduced revenue from the ATE segment, increased employee costs due to prior one-time bonus payments, and adverse foreign exchange fluctuations[50]. Assets and Liabilities - Total assets as of September 30, 2024, were 1,139.5 million MYR, compared to 1,159.0 million MYR as of December 31, 2023[11]. - Non-current assets increased to 480.3 million MYR from 354.6 million MYR year-on-year[11]. - Current liabilities decreased to 216,086 thousand MYR from 301,582 thousand MYR, representing a reduction of 28.4%[14]. - Total liabilities decreased to 229,731 thousand MYR from 311,069 thousand MYR, a decline of 26.1%[14]. - Total equity as of September 30, 2024, is 909,784 thousand MYR, an increase of 7.3% from 847,972 thousand MYR as of December 31, 2023[14]. - The company’s reserves increased to 897,445 thousand MYR from 835,632 thousand MYR, reflecting a growth of 7.4%[14]. Cash Flow - The cash flow from investing activities for the nine months ended September 30, 2024, was a net outflow of 136.9 million MYR, compared to 83.9 million MYR in the previous year[24]. - The cash flow from financing activities for the nine months ended September 30, 2024, was a net outflow of 30.5 million MYR, slightly improved from 33.2 million MYR in 2023[24]. Segment Performance - The ATE segment generated revenue of 196.5 million MYR for the nine months ended September 30, 2024, compared to 358.7 million MYR in the same period of 2023[28]. - The FAS segment reported revenue of 311.8 million MYR for the nine months ended September 30, 2024, down from 176.8 million MYR in the previous year[28]. - ATE segment revenue decreased by 47.8% to 187.2 million MYR compared to 358.3 million MYR in the same period last year, with a significant decline of 55.2% year-over-year[39]. - FAS segment revenue reached 305.0 million MYR for the nine months ended September 30, 2024, representing an 85.4% increase from 164.5 million MYR in the same period last year[42]. - Medical devices accounted for 76.9% of FAS segment revenue, up from 59.8% year-over-year, reflecting the industry's shift towards factory automation solutions[42]. - The automotive sector remains the largest contributor to the ATE segment, accounting for approximately 63.9% of total revenue, despite ongoing challenges in the market[39]. Market Outlook - The company anticipates continued weak demand in major segments, particularly in the automotive sector, for the remainder of 2024[31]. - The company expects to end the fiscal year with stable revenue momentum despite ongoing geopolitical risks and economic uncertainties[31]. - The company maintains a long-term optimistic outlook for the ATE segment, driven by its diversified product portfolio and participation in key growth areas[40]. Administrative and Other Expenses - Administrative expenses increased from RM 46.7 million in the previous year to RM 57.8 million, primarily due to a foreign exchange loss of RM 15.5 million compared to RM 6.2 million in the previous year[48]. - Net expected credit loss provisions for receivables increased by RM 1.2 million during the period[48]. - Administrative personnel costs decreased by RM 2.3 million, mainly due to lower employee benefits expenses[49]. Other Income and Recognition - The company recorded other income of 13.1 million MYR for the nine months, an increase from 9.2 million MYR in the previous year[7]. - Other income increased from 9.2 million MYR to 13.1 million MYR, driven by bank interest income and miscellaneous income, despite a net foreign exchange loss of approximately 10.6 million MYR[46]. - The company was recognized for the fifth time in Forbes' "Best Under a Billion" list in August 2024, reflecting its strong performance record[39].
槟杰科达(01665) - 2024 Q3 - 季度业绩